ABCB1 genetics predicts tacrolimus response in patients with ulcerative colitis. Running head: Tacrolimus Pharmacogenetics in IBD
K Herrlinger(Robert Bosch Hospital), Elke Schaeffeler(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Alexander Teml(Statistics Austria), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Stefan Winter(St. Vincenz-Krankenhaus Limburg), Hülya Koç, EF Stange(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel))
Cited by 0
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566